Codexis Announces the Publication of Research Demonstrating Proof of Concept for Chemoenzymatic Site-Selective Bioconjugation of Native Peptides

17.06.2022 - Collaboration with Merck published in Science magazine REDWOOD CITY, Calif., June 17, 2022 (GLOBE NEWSWIRE) - Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announces the ...

Related Keywords

,Ania Fryszkowska ,Carrie Mckim ,Exchange Commission ,Merck Research Laboratories ,Enabling Technologies ,Private Securities Litigation Reform Act ,Codexi Annual Report ,Codexi Quarterly Report ,Relations Contact ,